Archives: Speakers

Tennyson joined the Alnylam Clinical Operations department in November 2019 as a Clinical Trial Specialist for the Lumasiran program, where she has implemented creative lab sample solutions for a complex Phase III study. She joined Alnylam from Boston University Medical Center where she doubled as a Clinical Research Coordinator and Financial Manager in the Amyloidosis Center. Tennyson is a graduate of Boston University’s Questrom School of Business, where she received her MBA with a concentration in Health Sector Management in 2018 and Bachelors of Science in Business Administration in 2014.

Lesley Freese has been a leader in implementing clinical technology to improve the conduct of trials for more than a dozen years. She was a site coordinator in the field of ophthalmology for six years, running multiple trials and managing the arrays of technologies from pharmaceutical sponsors. This inspired Lesley to move into a project management role at DrugDev, a company providing solutions that were truly making life easier for sites. In 2017, DrugDev was acquired by IQVIA. Lesley now serves as Associate Director of Trial Operations and continues to work with sites and sponsors to apply digital technologies to accelerate clinical trials.

Jimmy is a Clinical Trial Specialist at Alnylam Pharmaceuticals. In his three and a half years in Clinical Operations, he has worked on studies from Phase 1 through 4, participated in multiple regulatory inspections, and helped to implement new projects and systems across clinical operations. He holds a Bachelor’s degree in Healthcare management and is currently pursuing a Master of Public Health degree at Boston University.

Elizabeth is the global strategic marketing manager for the food and beverage packaging markets that H.B. Fuller serves. With a passion and focus on sustainable solutions and extensive knowledge of the packaging industry and B2B marketing experience, Elizabeth acts as a connection between market and technology, customers and research and development.

Stuart Coleman is passionate about the opportunities for people to use technology, data and machines to learn new skills and shape a better future. He has diverse entrepreneurial and executive leadership experience in venture-backed, publicly listed and mission-led high growth technology, training and consulting organisations. He raised venture funding as well as built several businesses from cashflow. He has been founding Commercial Director at the Open Data Institute in 2012 and is delighted to have returned to support the leadership and team amidst an exciting new phase of growth in 2020.

Mira Doig, Ph.D., Technical Director at ABS Laboratories, Ltd.
Mira has over 30 years of experience performing regulated bioanalysis of drugs, metabolites, and biomarkers using GC-MS & LC-MS/MS, and has supported multiple drug development programs from discovery to MAA/NDA submission. In 1997 she established ABS Laboratories as a GLP/GCP accredited bioanalytical contract research organization, which was acquired by ACM Global Labs in 2018. Today, she continues to oversee ACM’s bioanalysis laboratory services and maintains technical and operational excellence.

I am a Chartered Accountant currently living in the West Midlands, United Kingdom.

I trained with a regional firm, Rabjohns (now part of Bishop Fleming), before joining Ernst & Young and KPMG, leaving them to build an outsourcing company.

My interests range from technology to sports having played football regularly and then running half marathons. I am also interested in entrepreneurship.

My passion is to allow accounting professionals to deliver more for their clients. We embrace technology and this helps us drive value to accounting firms around the globe.